CompletedPhase 4

Perioperative Respiratory Adverse events_sugammadex

South Korea174 participantsStarted 2022-06-27

Plain-language summary

Perioperative respiratory adverse events are common in children. We aimed to evaluate the effect of sugammadex on the incidence of perioperative respiratory adverse events in pediatric patients receiving tonsillectomy

Who can participate

Age range2 Years – 6 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Pediatric patients aged 2-6 years who were scheduled for tonsillectomy under general anesthesia were enrolled Exclusion Criteria: * a recent history of upper respiratory tract infection within 2 weeks of surgery * allergic reaction to sugammadex * renal failure * liver failure * arrhythmia

What they're measuring

Perioperative respiratory adverse events

Timeframe: from induction of anesthesia to end of operation, about 3 hours

Trial details

NCT IDNCT05354466

SponsorSeoul National University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-09-04

View on ClinicalTrials.gov More Respiratory Complication trials